Gebauer Roman, Chaloupecký Václav, Hučín Bohumil, Tláskal Tomáš, Komárek Arnošt, Janoušek Jan
Children's Heart Center, 2nd Faculty of Medicine Charles University and Motol University Hospital Prague Czech Republic.
Department of Probability and Mathematical Statistics, Faculty of Mathematics and Physics Charles University Prague Czech Republic.
J Am Heart Assoc. 2023 Oct 17;12(20):e024771. doi: 10.1161/JAHA.121.024771. Epub 2023 Oct 12.
Background To evaluate long-term outcome of tetralogy of Fallot repair analyzing an unbiased country-wide surgically treated population with tetralogy of Fallot. Methods and Results Retrospective analysis of consecutive patients aged <18 years who underwent tetralogy of Fallot repair at a single nationwide pediatric cardiac center. Death from any cause and need for surgical or catheter reintervention were the study end points. Cox regression analysis was used to identify related risk factors. A total of 917 patients (male, 56.3%) were analyzed. Staged repair was performed in 16.9%. Early mortality (24/917, 2.62% patients) was confined to the early surgical eras. Late mortality was 4.5% (40/893 patients). Survival probability was 95.1%, 93.8% and 91.9% at 10, 20 and 30 years after repair, respectively. Early surgical era (=0.013) and surgical/catheter reinterventions (<0.001) were multivariable predictors of late death. A total of 487 reinterventions were performed after initial repair in 253/917 patients (27.6%), with pulmonary artery revalvulation (196/917 patients, 21.4%) being most frequent. Probability of freedom from first reintervention was 89.0%, 73.3%, and 55.1% at 10, 20, and 30 years after primary repair, respectively. Transannular repair was associated with the need for pulmonary artery revalvulation (<0.001). Patients who underwent staged repair were more likely to need reinterventions on pulmonary arteries (<0.001). Conclusions In an unbiased nationwide cohort, tetralogy of Fallot repair carried a favorable survival of >90% at 30 years. Each reintervention significantly incrementally increased the risk of mortality. Type of initial repair predicted the need for specific surgical or catheter reinterventions.
通过分析一个全国范围内接受手术治疗的法洛四联症无偏倚人群,评估法洛四联症修复术的长期预后。方法与结果:对一家全国性儿科心脏中心连续收治的年龄小于18岁且接受法洛四联症修复术的患者进行回顾性分析。研究终点为任何原因导致的死亡以及手术或导管再次干预的需求。采用Cox回归分析确定相关危险因素。共分析了917例患者(男性占56.3%)。16.9%的患者接受了分期修复。早期死亡率(24/917,2.62%的患者)局限于早期手术时代。晚期死亡率为4.5%(40/893例患者)。修复术后10年、20年和30年的生存概率分别为95.1%、93.8%和91.9%。早期手术时代(=0.013)和手术/导管再次干预(<0.001)是晚期死亡的多变量预测因素。在917例患者中的253例(27.6%)初次修复后共进行了487次再次干预,其中肺动脉瓣置换术(196/917例患者,21.4%)最为常见。初次修复后10年、20年和30年无首次再次干预的概率分别为89.0%、73.3%和55.1%。跨环修复与肺动脉瓣置换术的需求相关(<0.001)。接受分期修复的患者更有可能需要对肺动脉进行再次干预(<0.001)。结论:在一个全国性无偏倚队列中,法洛四联症修复术30年生存率良好,超过90%。每次再次干预都会显著增加死亡风险。初次修复类型可预测特定手术或导管再次干预的需求。